BIOMAT Database Logo BIOMAT Database Logo

[Penicillin therapy of acute otitis media. A double-blind placebo-controlled study]. 1980

K I Meistrup-Larsen, and N Mygind, and J Thomsen, and P K Larsen, and V F Thomsen, and H Sørensen

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D010033 Otitis Media Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE. Middle Ear Inflammation,Inflammation, Middle Ear
D010404 Penicillin V A broad-spectrum penicillin antibiotic used orally in the treatment of mild to moderate infections by susceptible gram-positive organisms. Penicillin, Phenoxymethyl,Apocillin,Beromycin,Beromycin, Penicillin,Berromycin, Penicillin,Betapen,Fenoxymethylpenicillin,Pen VK,Penicillin V Potassium,Penicillin V Sodium,Penicillin VK,Phenoxymethylpenicillin,V-Cillin K,Vegacillin,Penicillin Beromycin,Penicillin Berromycin,Phenoxymethyl Penicillin,Potassium, Penicillin V,Sodium, Penicillin V,V Cillin K,V Sodium, Penicillin,VCillin K
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

K I Meistrup-Larsen, and N Mygind, and J Thomsen, and P K Larsen, and V F Thomsen, and H Sørensen
Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study.
June 2007, Clinical nutrition (Edinburgh, Scotland),
K I Meistrup-Larsen, and N Mygind, and J Thomsen, and P K Larsen, and V F Thomsen, and H Sørensen
Antibiotic treatment of children with secretory otitis media. A randomized, double-blind, placebo-controlled study.
April 1989, Archives of otolaryngology--head & neck surgery,
K I Meistrup-Larsen, and N Mygind, and J Thomsen, and P K Larsen, and V F Thomsen, and H Sørensen
Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial.
October 2000, Lancet (London, England),
K I Meistrup-Larsen, and N Mygind, and J Thomsen, and P K Larsen, and V F Thomsen, and H Sørensen
Long-term antibiotic treatment of children with secretory otitis media: a double-blind placebo-controlled study.
January 1988, Acta oto-laryngologica. Supplementum,
K I Meistrup-Larsen, and N Mygind, and J Thomsen, and P K Larsen, and V F Thomsen, and H Sørensen
Topical lignocaine for pain relief in acute otitis media: results of a double-blind placebo-controlled randomised trial.
January 2008, Archives of disease in childhood,
K I Meistrup-Larsen, and N Mygind, and J Thomsen, and P K Larsen, and V F Thomsen, and H Sørensen
Probiotics and prebiotics in preventing episodes of acute otitis media in high-risk children: a randomized, double-blind, placebo-controlled study.
August 2013, The Pediatric infectious disease journal,
K I Meistrup-Larsen, and N Mygind, and J Thomsen, and P K Larsen, and V F Thomsen, and H Sørensen
Therapy of acute otitis media: myringotomy, antibiotics, or neither? A double-blind study in children.
October 1981, Lancet (London, England),
K I Meistrup-Larsen, and N Mygind, and J Thomsen, and P K Larsen, and V F Thomsen, and H Sørensen
Local penicillin therapy for acute otitis media.
May 1949, Concours medical,
K I Meistrup-Larsen, and N Mygind, and J Thomsen, and P K Larsen, and V F Thomsen, and H Sørensen
Co-amoxiclav in recurrent acute otitis media: placebo controlled study.
December 1991, BMJ (Clinical research ed.),
K I Meistrup-Larsen, and N Mygind, and J Thomsen, and P K Larsen, and V F Thomsen, and H Sørensen
[Penicillin therapy of acute otitis media without complications].
May 1950, Maanedsskrift for praktisk laegegerning og social Medicin,
Copied contents to your clipboard!